Multiple defects in macrophage antibacterial responses support intracellular survival of <i> <i>Mycobacterium</i> abscessus </i> in cystic fibrosis

A Abdullah A. Tarique (Children’s Health and Environment Program, Child Health Research Centre, The University of Queensland) S Stefan Emming (Institute for Molecular Bioscience, The University of Queensland) D Dean Kelk (Children’s Health and Environment Program, Child Health Research Centre, The University of Queensland) J Jayden Logan (Children’s Health and Environment Program, Child Health Research Centre, The University of Queensland) D Divya Ramanth (Australian Infectious Diseases Research Centre, The University of Queensland) E Emma K. Dalton (Australian Infectious Diseases Research Centre, The University of Queensland) K Kaustav Das Gupta (Australian Infectious Diseases Research Centre, The University of Queensland) T Tamara Blake (Children’s Health and Environment Program, Child Health Research Centre, The University of Queensland) J James E. B. Curson (Australian Infectious Diseases Research Centre, The University of Queensland) S Syeda Farhana Afroz (Australian Infectious Diseases Research Centre, The University of Queensland) M Matthew J. Sweet (Australian Infectious Diseases Research Centre, The University of Queensland) C Claire E. Wainwright (Respiratory and Sleep Medicine, Queensland Children’s Hospital) R Ronan Kapetanovic (Institute for Molecular Bioscience, The University of Queensland) L Laurent Kremer S Scott C. Bell (Australian Infectious Diseases Research Centre, The University of Queensland) E Emmanuelle Fantino (Children’s Health and Environment Program, Child Health Research Centre, The University of Queensland) P Peter D. Sly (Children’s Health and Environment Program, Child Health Research Centre, The University of Queensland)

Abstract

The prevalence of Mycobacterium abscessus (MABS) infections in people with cystic fibrosis (pwCF) is increasing. Macrophages are key phagocytic cells that recognize bacteria via cell surface receptors, engulf them into phagosomes, and then utilize diverse killing strategies. Here, we used human primary monocyte-derived macrophages (MDMs) from healthy controls (HCs) and pwCF to investigate how they processed and killed MABS. Expression of phagocytosis-related pattern recognition receptors (TLR2, Dectin-1, Dectin-2, and MARCO), engulfment of MABS, and lysosomal acidity were all reduced in CF-MDMs. MABS-infected CF-MDMs also had reduced mitochondrial mass, mitochondrial reactive oxygen species (mitoROS) production, relative intracellular zinc levels and inducible mRNA expression of the antibacterial zinc transporters, SLC30A1 and SLC39A8. Stimulation of mitoROS production in HC-MDMs with antimycin A reduced intracellular loads of MABS, confirming that MABS are sensitive to this mechanism of killing and suggesting that the mitoROS defect in MABS-infected CF-MDMs compromises bacterial killing. Accordingly, CF-MDMs failed to control MABS infection, with these cells allowing significantly increased intracellular MABS survival and expansion over 6 d. While treatment with the CFTR modulator, elexacaftor–tezacaftor–ivacaftor (ETI) did increase CFTR channel function and corrected CF macrophage functions to some degree, this was not sufficient to increase MABS killing. Taken together, our findings suggest important roles for functional CFTR in internalization and killing of MABS within macrophages, with CFTR dysfunction supporting MABS survival and replication in macrophages. Under our experimental conditions, ETI treatment failed to fully restore macrophage functions against MABS, highlighting the need for alternative, host-targeted approaches for improving macrophage functions in CF.

Article Details

Volume / Issue Vol. 123, Issue 22
Published June 02, 2026
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (17)

A

Abdullah A. Tarique

Children’s Health and Environment Program, Child Health Research Centre, The University of Queensland

S

Stefan Emming

Institute for Molecular Bioscience, The University of Queensland

D

Dean Kelk

Children’s Health and Environment Program, Child Health Research Centre, The University of Queensland

J

Jayden Logan

Children’s Health and Environment Program, Child Health Research Centre, The University of Queensland

D

Divya Ramanth

Australian Infectious Diseases Research Centre, The University of Queensland

E

Emma K. Dalton

Australian Infectious Diseases Research Centre, The University of Queensland

K

Kaustav Das Gupta

Australian Infectious Diseases Research Centre, The University of Queensland

T

Tamara Blake

Children’s Health and Environment Program, Child Health Research Centre, The University of Queensland

J

James E. B. Curson

Australian Infectious Diseases Research Centre, The University of Queensland

S

Syeda Farhana Afroz

Australian Infectious Diseases Research Centre, The University of Queensland

M

Matthew J. Sweet

Australian Infectious Diseases Research Centre, The University of Queensland

C

Claire E. Wainwright

Respiratory and Sleep Medicine, Queensland Children’s Hospital

R

Ronan Kapetanovic

Institute for Molecular Bioscience, The University of Queensland

L

Laurent Kremer

S

Scott C. Bell

Australian Infectious Diseases Research Centre, The University of Queensland

E

Emmanuelle Fantino

Children’s Health and Environment Program, Child Health Research Centre, The University of Queensland

P

Peter D. Sly

Children’s Health and Environment Program, Child Health Research Centre, The University of Queensland